Evidence map›Paper›PMID 31412836›Full record

ArticleBMC public health2019

Estimated dengue force of infection and burden of primary infections among Indian children.

Amit Bhavsar, Clarence C Tam, Suneela Garg, Guru Rajesh Jammy, Anne-Frieda Taurel, Sher-Ney Chong, Joshua Nealon

Registry-linked trialAbstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01477671 (Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01477671 completednot on this map

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India

TypeobservationalSponsorSanofi Pasteur, a Sanofi CompanyRan2011 to 2013Enrolled667ConditionsDengue, Dengue Fever, Dengue Hemorrhagic Fever
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amit BhavsarSanofi Pasteur- India, Mumbai, India.
Clarence C TamPresent address: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Suneela GargMaulana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi, Delhi, 10002, India.
Guru Rajesh JammySHARE INDIA - Mediciti Institute of Medical Sciences, Hyderabad, India.
Anne-Frieda TaurelSanofi Pasteur- Singapore, Asia & JPAC, 38 Beach Road # 18-11, South Beach Tower, Singapore, 189767, Singapore.
Sher-Ney ChongPresent address: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Joshua NealonSanofi Pasteur- Singapore, Asia & JPAC, 38 Beach Road # 18-11, South Beach Tower, Singapore, 189767, Singapore. Joshua.nealon@sanofi.com.ORCID http://orcid.org/0000-0003-1538-4636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComprehensive, age-stratified dengue surveillance data are unavailable from India and many more dengue cases occur than are reported. Additional information on dengue transmission dynamics can inform understanding of disease endemicity and infection risk.

methodsUsing age-stratified dengue IgG seroprevalence data from 2556 Indian children aged 5-10 years, we estimated annual force of infection (FOI) at each of 6 sites using a binomial regression model. We estimated the ages by which 50 and 70% of children were first infected; and predicted seroprevalence in children aged 1-10 years assuming constant force-of-infection. Applying these infection rates to national census data, we then calculated the number of primary dengue infections occurring, annually, in Indian children.

resultsAnnual force-of-infection at all sites combined was 11.9% (95% CI 8.8-16.2), varying across sites from 3.5% (95% CI 2.8-4.4) to 21.2% (95% CI 18.4-24.5). Overall, 50 and 70% of children were infected by 5.8 (95% CI 4.3-7.9) and 10.1 (95% CI 7.4-13.7) years respectively. In all sites except Kalyani, > 70% of children had been infected before their 11th birthday, and goodness-of-fit statistics indicated a relatively constant force-of-infection over time except at two sites (Wardha and Hyderabad). Nationwide, we estimated 17,013,527 children (95% CI: 14,518,438- 19,218,733), equivalent to 6.5% of children aged < 11 years, experience their first infection annually.

conclusionsDengue force-of-infection in India is comparable to other highly endemic countries. Significant variation across sites exists, likely reflecting local epidemiological variation. The number of annual primary infections is indicative of a significant, under-reported burden of secondary infections and symptomatic episodes.

trial registrationRegistered retrospectively with clinicaltrials.gov ( NCT01477671 ; 18/11/2011) and clinical trials registry of India (ctri.nic.in; CTRI/2011/12/002243 ; 15/12/2011). Date of enrollment of 1st subject: 22/9/2011.

Indexed as

Endemic DiseasesChildChild, PreschoolDengueFemaleHumansIndiaInfantMaleModels, StatisticalSeroepidemiologic StudiesDengueEndemic diseasesFlavivirusIndiaInfectionSeroepidemiologic studies

Identifiers

PMID31412836
PMCPMC6694619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.